MIMS

First published in 1959, MIMS has grown to be the essential prescribing and clinical reference for UK general practice.

MIMS provides concise expert summaries of prescribing information for prescription products alongside a range of other quick-reference prescribing tools including comparison tables, guideline summaries, visual guides and a constantly updated list of drug shortages.

MIMS is updated constantly online, with changes incorporated daily including the addition of new drugs and formulations, updates to prescribing information, price changes, and the removal of products that are no longer available.

MIMS content is compiled by our team of pharmacists for the benefit of healthcare professionals in Great Britain and is not influenced by marketing information from pharmaceutical companies.

MIMS drug summaries are based on product Summaries of Product Characteristics (SPCs) for Great Britain. 

Accessing MIMS

Healthcare professionals may subscribe to MIMS online or by emailing help@shop.haymarket.com.

If you’d like access for 10 or more users at your company we can offer substantial discounts on subscription rates. Please email emma.broderick@haymarket.com.

The last print issue of MIMS will be the December 2023 edition.

Advertising information

Advertising enquiries can be directed to our advertising team, details of which can be found on our MIMS advertising information page . Advertisements are accepted for publication only upon Haymarket Media Group Limited's standard Terms of Acceptance of Advertising, copies of which are available from the advertising sales department.

Sustainability

The climate crisis is a health crisis, and at MIMS we are keen to play our part in tackling this global challenge not only by reducing our own carbon footprint, but also by supporting UK healthcare professionals and pharmaceutical companies in their efforts to reduce the impact of healthcare - particularly prescribing - on the environment.

To support greener prescribing, we are initially focussing on ways to help reduce the use of pressurised metered-dose inhalers, which the NHS has identified as a key priority in its plan to achieve net zero by 2040. Inhalers with a lower carbon footprint (ie, dry-powder and soft-mist devices) are now highlighted in MIMS with a leaf symbol. In addition, MIMS provides a table to help healthcare professionals compare the carbon footprints of all inhalers available in the UK. For these efforts MIMS was shortlisted in the PPA (Professional Publishers Association) 2023 awards for 'Sustainability Initiative of the Year'.

In terms of MIMS’ own carbon footprint, this has been reduced to a minimum by ceasing the printing and delivery of print copies from 2024. 

MIMS is published by Haymarket Media Group, which is certified by BSI to environmental standard ISO14001 and energy management standard ISO50001. In an independent audit by EcoVadis, Haymarket UK was awarded a ‘Bronze’ sustainability rating for 2022, and was ranked in the top 21% of companies in the publishing industry. Read more about Haymarket's work toward economic, environmental and social sustainability.

Sustainability is a continuous journey and we are determined to keep building on these efforts. We welcome all ideas and suggestions - please email mims@haymarket.com.

Disclaimer

You acknowledge that whilst Haymarket endeavours to ensure that information on this site is accurate and complete at the time of first publication, it is provided only for general information, is not intended to address your particular requirements and does not constitute any form of advice or recommendation by Haymarket. You acknowledge that the information on this site does not necessarily reflect the views and opinions of Haymarket, that such information should not be relied upon by you in making (or refraining from making) any specific investment or other business, professional or personal decisions and that you should seek independent professional advice before making any such decision. You also acknowledge that views and opinions expressed in content submitted by third party contributors are views and opinions of the authors of that content and not Haymarket’s views and opinions.